These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7548803)

  • 1. Rise of plasma myeloperoxidase during interferon therapy.
    Nakamuta M; Ohashi M; Fukutomi T; Tanabe Y; Hiroshige K; Nawata H
    J Gastroenterol Hepatol; 1995; 10(3):277-80. PubMed ID: 7548803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
    Hosoi H; Imai M; Yamanaka M
    J Gastroenterol Hepatol; 1992; 7(4):411-6. PubMed ID: 1515568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C.
    Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Durand D
    Nephron; 1996; 74(3):512-6. PubMed ID: 8938673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: agranulocytosis induced by interferon-alpha therapy for chronic hepatitis C.
    Higashi Y; Sakai K; Tada S; Miyase S; Nakamura T; Kamio T; Haraguchi O
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1012-5. PubMed ID: 8985818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
    Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH
    Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon alpha and chronic viral hepatitis].
    Ouzan D
    Rev Prat; 1994 Sep; 44(13):1714-8. PubMed ID: 7939251
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.
    Peck-Radosavljevic M; Wichlas M; Homoncik-Kraml M; Kreil A; Hofer H; Jessner W; Gangl A; Ferenci P
    Gastroenterology; 2002 Jul; 123(1):141-51. PubMed ID: 12105843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of viral hepatitis.
    Mutimer D
    Hosp Med; 1998 Apr; 59(4):264-5. PubMed ID: 9722361
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ; Azzouz M; Van Thiel DH
    Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
    Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
    BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of recombinant interferon alpha 2A versus alpha 2 beta on myelosuppression in healthy adult volunteers.
    Wong S; Kaita K; Gauthier T; Jones S; Minuk GY
    Hepatogastroenterology; 1996; 43(7):301-5. PubMed ID: 8682483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon.
    Kakumu S; Ishikawa T; Mizokami M; Orido E; Yoshioka K; Wakita T; Yamamoto M
    J Med Virol; 1991 Sep; 35(1):32-7. PubMed ID: 1940881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
    Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
    AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.
    Peck-Radosavljevic M; Wichlas M; Pidlich J; Sims P; Meng G; Zacherl J; Garg S; Datz C; Gangl A; Ferenci P
    Hepatology; 1998 Nov; 28(5):1424-9. PubMed ID: 9794931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy.
    Nomura H; Miyagi Y; Tanimoto H; Yamashita N; Ito K; Masaki N; Mizokami M
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1461-6. PubMed ID: 22554247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura.
    Yoshida EM; Rock NR; Zeng L; Haniak WA; Anderson FH
    Am J Gastroenterol; 1995 May; 90(5):854-5. PubMed ID: 7605454
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of side effects during therapy with different types of alpha interferon: a randomised controlled trial comparing recombinant alpha 2b versus leukocyte interferon in the therapy of naive patients with chronic hepatitis C.
    Ascione A; De Luca M; Di Costanzo GG; Picciotto FP; Lanza AG; Canestrini C; Morisco F; Tuccillo C; Caporaso N
    Curr Pharm Des; 2002; 8(11):977-80. PubMed ID: 11945144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.
    Sugano S; Suzuki T; Watanabe M; Ohe K; Ishii K; Okajima T
    Am J Gastroenterol; 1998 Dec; 93(12):2441-4. PubMed ID: 9860406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.